Sunitinib for the First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma
Technology Appraisal Guidance No. 169 Source: National Institute for Health and Clinical...
Jump to:
Click on a letter to go to fact sheets beginning with that letter.
1. Guidance 1.1 Rivaroxaban, within its marketing authorisation, is recommended as an...
Technology Appraisal Guidance No. 169 Source: National Institute for Health and Clinical...
Technology Appraisal Guidance No. 168 Source: National Institute for Health and Clinical...
Technology Appraisal Guidance No. 162 Source: National Institute for Health and Clinical...
Technology Appraisal Guidance No. 163 Source: National Institute for Health and Clinical...
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.